Geode Capital Management’s AEON Biopharma AEON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.7K | Buy |
+20,695
| New | +$15.7K | ﹤0.01% | 4390 |
|
|
2025
Q1 | – | Sell |
-3,497
| Closed | -$136K | – | 4478 |
|
|
2024
Q4 | $136K | Buy |
3,497
+120
| +4% | +$4.67K | ﹤0.01% | 4014 |
|
|
2024
Q3 | $255K | Buy |
3,377
+782
| +30% | +$59.1K | ﹤0.01% | 3823 |
|
|
2024
Q2 | $196K | Buy |
2,595
+101
| +4% | +$7.64K | ﹤0.01% | 3916 |
|
|
2024
Q1 | $2.08M | Buy |
2,494
+102
| +4% | +$85.2K | ﹤0.01% | 3097 |
|
|
2023
Q4 | $1.24M | Buy |
2,392
+12
| +0.5% | +$6.22K | ﹤0.01% | 3266 |
|
|
2023
Q3 | $960K | Buy |
2,380
+2,175
| +1,061% | +$877K | ﹤0.01% | 3341 |
|
|
2023
Q2 | $107K | Hold |
205
| – | – | ﹤0.01% | 4312 |
|
|
2023
Q1 | $150K | Hold |
205
| – | – | ﹤0.01% | 4174 |
|
|
2022
Q4 | $148K | Hold |
205
| – | – | ﹤0.01% | 4241 |
|
|
2022
Q3 | $145K | Buy |
+205
| New | +$145K | ﹤0.01% | 4378 |
|